Enfusion, Inc. (NYSE:ENFN) Short Interest Update

Enfusion, Inc. (NYSE:ENFN - Get Free Report) was the recipient of a large drop in short interest in the month of October. As of October 15th, there was short interest totalling 1,520,000 shares, a drop of 14.1% from the September 30th total of 1,770,000 shares. Approximately 3.1% of the company's shares are short sold. Based on an average daily volume of 376,900 shares, the short-interest ratio is currently 4.0 days.

Institutional Inflows and Outflows

A number of institutional investors and hedge funds have recently added to or reduced their stakes in ENFN. Allspring Global Investments Holdings LLC purchased a new stake in shares of Enfusion during the first quarter worth $44,000. Wasatch Advisors LP raised its position in Enfusion by 34.2% during the first quarter. Wasatch Advisors LP now owns 792,083 shares of the company's stock valued at $7,327,000 after acquiring an additional 201,771 shares in the last quarter. Principal Financial Group Inc. acquired a new stake in Enfusion in the first quarter valued at approximately $452,000. Swiss National Bank grew its position in Enfusion by 20.0% in the first quarter. Swiss National Bank now owns 69,700 shares of the company's stock worth $645,000 after acquiring an additional 11,600 shares in the last quarter. Finally, Susquehanna Fundamental Investments LLC acquired a new position in shares of Enfusion during the 1st quarter worth $122,000. 81.05% of the stock is owned by hedge funds and other institutional investors.

Enfusion Stock Up 1.0 %

Shares of Enfusion stock traded up $0.10 during midday trading on Tuesday, hitting $9.26. The company's stock had a trading volume of 166,383 shares, compared to its average volume of 365,972. Enfusion has a 1-year low of $7.52 and a 1-year high of $10.45. The firm has a market capitalization of $1.19 billion, a P/E ratio of 231.31, a PEG ratio of 2.46 and a beta of 0.92. The stock has a 50-day simple moving average of $8.68 and a 200-day simple moving average of $8.85.

Enfusion (NYSE:ENFN - Get Free Report) last announced its quarterly earnings data on Tuesday, August 6th. The company reported $0.02 EPS for the quarter, missing analysts' consensus estimates of $0.03 by ($0.01). Enfusion had a return on equity of 6.17% and a net margin of 1.98%. The business had revenue of $49.46 million for the quarter, compared to analyst estimates of $50.27 million. As a group, sell-side analysts predict that Enfusion will post 0.07 earnings per share for the current year.

Enfusion Company Profile

Enfusion, Inc provides software-as-a-service solutions for investment management industry in the United States, Europe, the Middle East, Africa, and the Asia Pacific. The company provides Portfolio Management System, which generates a real-time investment book of record that consists of valuation and risk tools, which allows users to analyze aggregated or decomposed portfolio data for chief investment officers (CIOs) and portfolio managers; and Order and Execution Management System that enables portfolio managers, traders, compliance teams, and analysts to electronically communicate trade orders for a variety of asset classes, manage trade orders, and systemically enforce trading regulations and internal guidelines.